Profile

Recruiters: To view this profile, please Register / Login

Jobseekers: To make your profile available to Recruiters for free, opt for Premium Membership

Dr Venkatesh Mushini DHA licence unique ID 94768574

Candidate ID: 1650318

Career Summary

I am Dr Venkatesh Mushini MD, DM, MRCP SCE - CONSULTANT MEDICAL ONCOLOGIST with 10 years of experience in the field of Oncology. Expertise in treating all types of cancers including both Solid & Hematological malignancies. Well experienced in the administration of Chemotherapy, Precision therapies,

Skill Set

Expertise in treating all types of cancer including both solid and Hematological malignancies. Expertised in treating cancers with chemotherapy,Targeted therapy,Immunotherapy & Hormonal therapy. Certified in Pain & Palliative care. Actively involved in Clinical research & academic activities.

Professional Information

Total Experience : 10

Nationality : India

Qualification Level : Doctorate

Job Function : Doctor / Medical Research / Dean / Medical Professors

Work Location Preference : Kuwait, Bahrain, Oman, Saudi Arabia, Qatar, UAE

Detailed Profile

Dr.VENKATESH MUSHINI : MD,DM,MRCP-SCE - CONSULTANT MEDICAL ONCOLOGIST
Bahrain, +973 35112087
+91 8520891129
venkateshmushini08@gmail.com

PROFESSIONAL SUMMARY

Consultant Medical Oncologist and Hemato Oncologist well experienced (10 yrs) in establishing the oncology departments, implementing regulatory-compliant protocols, and leading multidisciplinary teams. Proficient in the diagnosis, staging, and management of solid and haematological cancers across adult and paediatric patients, with expertise in molecular genomic profiling and advanced treatment modalities. Demonstrated leadership in organising tumour boards, conducting academic programmes, and training healthcare professionals while maintaining compassionate patient-centred care. Strong communication, interpersonal, and decision-making skills complemented by a commitment to ethical practice and continuous professional development. Dedicated to advancing oncology care through clinical teaching, research, and active participation in cancer awareness initiatives.

EXPERIENCE

CONSULTANT MEDICAL ONCOLOGIST AND HEMATOONCOLOGIST, 02/2023 - Current
Royal Bahrain Hospital, Bahrain

• Established the Department of Medical oncology and implemented Policies and Protocols as per the Regulatory authority (NHRA)
• Expertise in diagnosis and management of Solid cancers as well as Haematological cancers
a) Screening and Diagnosis of cancer
b) Staging workup
c) Discussing therapeutic options with patients and family
d) Arranging and supervising the therapies including the management of complications
e) After treatment care and follow up
• Established the Tumour board and Conducted Multidisciplinary meetings
• Good communication skills and maintaining healthy relationships with colleagues, patients and their families
• Effective decision making skills
• Active participation in Academic programs, Seminars, CME"s, Cancer awareness programs, Training the nurses and staff, Clinical teaching and Research.

CONSULTANT MEDICAL ONCOLOGIST AND HEAD OF DEPARTMENT OF ONCOLOGY, 02/2022 - 01/2023
Padiyath Medicity Hospital du Cinquantanaire, Democratic Republic of Congo

• Efficient in diagnosing the cancer by interpreting the Biopsy reports, Endoscopy, X-ray, USG, CT

scanning, MRI, PET CT , Expertise in Molecular Genomic Profiling of the Tumor.

• Expertise in treating Adult and Pediatric oncology, All types of cancers (Solid as well as Hematological Cancers) cases with detailed diagnosis, treatment, prognosis and follow up with patient centred care.

• Monitoring Patient throughout the course of the the treatment including palliative care.

CONSULTANT MEDICAL ONCOLOGIST AND HEMATOONCOLOGIST, 08/2017 - 01/2022
Surya Global Hospital and Cancer Research Centre, India.

• Managed various Solid and Hematological malignancies in Adult and Pediatric patients
• Comprehensive management of cancer patients, safe delivery of systemic cancer treatments and the management of treatment side effects and disease symptoms
• Involved in cancer screening, diagnosis and prevention
• Liaising with other medical and non-medical staff in the hospital to ensure quality treatment
• Undertaken managerial responsibilities such as planning the workload and staffing of the department.
• Actively participated in cancer awareness programmes, seminars, CME"s, cancer research in addition to clinical care.
• Established Tumour board and Multidisciplinary meetings.

CONSULTANT CLINICAL ONCOLOGIST, 01/2014 - 07/2014
Susrutha Cancer Hospital, India.

• Delivering treatment plans tailored to the individual needs of each patient and provided a range of treatments including chemotherapy, hormonal therapy, targeted therapy
• Use of advanced techniques of Radiotherapy as a part of multimodality approach according to standard protocols
• Follow up care of patients and management Acute and Long term side effects of cancer therapies




SKILLS

• Strong communication
• Interpersonal skills
• Leadership skills
• Compassionate
• Hard working
• Sincere
• Responsible
• Ethical
• Problem Solving

MEMBERSHIPS

• 2019, Association of Immuno Oncology Society of India (IOSI)
• 2017, European Society of Medical Oncology (ECMO)
• 2015, Indian Society of Medical & Pediatric Oncology (ISMPO)
• 2013, Indian Medical Association (IMA)
• 2011, Association of Radiation Oncologists of India (AROI)

LANGUAGES

Hindi:Advanced

C1 English: C1 Advanced

CERTIFICATIONS

• European Society of Medical Oncology Board (ECMO), 2017
• John Hopkins Online Certification - Immunotherapy in Adjuvant and Metastatic Lung Cancer, 2019
• The University of Texas MD Anderson Cancer Center Online Certification Immunotherapy in Cancer Patients & Role of EGFR TKIs in Lung Cancer, 2019
• Duke Health Online Certification - Advanced Breast Cancer Management, 2019

• EUROPEAN SOCIETY OF IMMUNO-ONCOLOGY, 2021


PERSONAL INFORMATION

• Title: MD, DM, MRCP (SCE) - Consultant Medical Oncologist
• Date of birth : 08/11/1985
• Nationality : Indian

EDUCATION

Royal college of physicians, U.K, 2021
MRCP Part I

Royal college of physicians, U.K, 2019
MRCP SCE: MEDICAL ONCOLOGY

Dr.NTR University, India, 2014 to, 2017
DM : MEDICAL ONCOLOGY

Osmania Medical college, Dr. NTR UNIVERSITY 2010 to, 2013
MD : RADIATION ONCOLOGY

Osmania Medical college, Dr.NTR UNIVERSITY 2007 to, 2009
MBBS : INTERNSHIP

Government Medical college, Dr.NTR UNIVERSITY 2002 to, 2007
MBBS : Bachelor of Medicine and Surgery

HONOURS

• Best of ASCO, 2018, Delivered National Level Talk on role of Immunotherapy in Squamous cell ca Lung (Key Note 407 Study)
• State level speaker program 2018, on Role of Sub Cutaneous Herceptin in Breast Cancer
• State Level Talk, 2018, on updates in CINV and role of Akynzeo(NEPA)
• Participated as a key speaker, 2018, in several Cancer Awareness Programs conducted at community level
• Attended Several International and National Conferences, 2018, as a Delegate and Speaker in last 10 years (World Cancer Congress-2018; ASCO-2017)
• Honoured at District level Cancer Care in India, 2019
• Conducted CME, 2019, on overview of Chemotherapy and Advances in Medical Oncology


PAPERS AND PUBLICATIONS

• As Primary Author
• A rare case of Non Hodgkin Lymphoma of Nasopharyngeal origin with unusual pattern of relapse; ISMPO 2015 Abstract
• A rare incidence of late recurrence of primary as double malignancy ; ISMPO 2015 Abstract
• A rare presentation of carcinoma lung as soft tissue mass ; ISMPO 2015 Abstract
• Clinical profile &therapy of Hepatocellular carcinoma in a tertiary care -Hospital in Andhrapradesh from South India A study of 182 cases - ACOS 2016 ; Oral presentation.
• Clinical profile and outcomes of acute myeloid leukemia: An institutional experience from South India HEMATOCON 2016 - Abstract

• As Second Author

• Synchronous Occurrence of CML and Ca Breast-A RareCombination-HEMATOCON,2016-Abstract
• The different clinical scenarios of Plasmablastic Myeloma: A report of two cases of very rare variant of multiple Myeloma-ISMPO, 2016-Abstract
• Paediatric CML Data - An Insitutional experience from South India-APCON,2017-Abstract
• Publications Peer reviewed - Corresponding Author
• Clinical profile and Therapy of Hepatocellular Carcinoma at a Tertiary Care Institute from South India: A Retrospective study of 182 patients- IJCER Vol 5no 1,january june2017DOI:http:/ dx.doi.org/10.21088/ijcer.2321.9815.5117.5
• A study of COX-2 inhibitor celecoxib and chemoradiation in patients with locally advanced Cervical Cancer - Jebmh.com Co author J. Evid. Based Med. Healthc., pISSN- 2349-2562, eISSN-
2349-2570/ Vol. 3/Issue 68/Aug. 25, 2016
• Treatment Response and Locoregional Control in Locally Advanced Oral Cavity Cancers with Concurrent Chemoradiation and Radiation Alone Co author Indian Journal of Cancer Education and Research 53 Volume 5 Number 2, July - December 2017 DOI: http:/ dx.doi.org/10.21088
/ijcer.2321.9815.5217.1
• Comparative Study of Folfox 4 Versus Capeox Chemotherapy Regimens in Adjuvant Therapy and Metastatic Colorectal Cancer Indian Journal of Cancer Education and Research Volume 7 Number 2, July - December 2019 DOI: http:/ dx.doi.org/10.21088/ijcer.2321.9815.7219.6
• Clinical Profile and Outcomes of Acute Myeloid Leukemia: An Institutional Experience from South India. Indian Journal of Cancer Education and Research Volume 7 Number 2, July - December 2019 DOI: http:/ dx.doi.org/10.21088/ijcer.2321.9815.7219.7

REFERENCES

• Dr.Silas Charles MD American Board Radiation oncologist ., +1(321)7957390, Florida ,USA.
• Dr.BHPS. Veerraju Consultant Surgical oncologist MD Global cancer Hospital., +91 9848124080., India